🔓 Unlock the full profile of Mahadevan Narayanamoni (Akna Medical Pvt Ltd (Aknamed)), including verified contact details, financial insights, and professional associations.

See Mahadevan Narayanamoni Full Profile

Below are the ✅ Verified Contact Details to help you connect directly:

Email: mah*****@akn******.com

Mobile: 64967*****

Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)

Key Insights You Should Know About This Individual

  • Mahadevan Narayanamoni is the Co-Founder and Chairman of Akna Medical Pvt Ltd (Aknamed), a company established in May 2018, focusing on innovative medical solutions and products.
  • Under Mahadevan's leadership, Akna Medical has aimed to address critical healthcare needs by developing unique medical devices and technologies.
  • From March 2015 to March 2019, Mahadevan served as a Senior Advisor at TPG Capital, offering strategic guidance in investment and business development that contributed to the growth of healthcare ventures.
  • During the tenure from December 2015 to March 2019, Mahadevan held a Director position at Quality Needles Pvt. Ltd., overseeing operations and enhancing product quality.
  • Mahadevan was also a Director at Sironix Medtech from May 2015 to March 2019, contributing to advancements in medical technology and device innovation.
  • At Clinisupplies, Mahadevan served as a Director from May 2015 to September 2018, playing a critical role in expanding the company's reach in the medical supply industry.
  • Throughout the career, Mahadevan has faced challenges in the medical sector, including regulatory hurdles and market competition, and has successfully navigated these to establish robust business frameworks.
  • The strategic roles held in multiple medical companies demonstrate Mahadevan's commitment to quality in healthcare delivery and innovation in medical technology.
  • Mahadevan's contributions have significantly impacted the landscape of medical devices and supplies, underscoring a dedication to improving patient care and healthcare outcomes.